Analysis of alternative splicing patterns in the cystic fibrosis transmembrane conductance regulator gene using mRNA derived from lymphoblastoid cells of cystic fibrosis patients
- PMID: 8840112
- DOI: 10.1159/000472186
Analysis of alternative splicing patterns in the cystic fibrosis transmembrane conductance regulator gene using mRNA derived from lymphoblastoid cells of cystic fibrosis patients
Abstract
Using in vitro amplification of cDNA by the polymerase chain reaction, we analyzed alternatively spliced events of cystic fibrosis transmembrane conductance regulator gene in lymphoblastoid cells. Ten alternatively spliced transcripts were identified using analysis of 6 overlapping segments of amplified cDNA, 4 of which have not been described previously. These include transcripts lacking exon 16, 17b, 22 and a transcript resulting from the use of a cryptic acceptor and donor splice sites. Moreover, in 2 cystic fibrosis (CF) patients bearing nonsense mutations E60X or W1282X, we observed that nonsense mutations are associated with an alteration of splice site selection in vivo resulting in exon skipping of constitutive exons or in the use of cryptic splice sites. In addition, even though lymphoblastoid cells are not the relevant tissue to address the question of the relationship between clinical respiratory phenotype and genotype, our results concerning adult CF patients (delta F508/ delta F508) suggest that individual-specific RNA splicing patterns could influence the severity of the CF pulmonary disease. If this phenomenon of alternative splicing events proves to be significant in CF and to be a common feature of disease genes, the study of RNA splicing could become an important tool for the analysis of the genotype-phenotype relationship in many inherited disorders.
Similar articles
-
Exon 9 of the CFTR gene: splice site haplotypes and cystic fibrosis mutations.Hum Genet. 1994 Jan;93(1):67-73. doi: 10.1007/BF00218916. Hum Genet. 1994. PMID: 7505767
-
Genetic basis of variable exon 9 skipping in cystic fibrosis transmembrane conductance regulator mRNA.Nat Genet. 1993 Feb;3(2):151-6. doi: 10.1038/ng0293-151. Nat Genet. 1993. PMID: 7684646
-
Exon skipping through the creation of a putative exonic splicing silencer as a consequence of the cystic fibrosis mutation R553X.J Med Genet. 2007 May;44(5):341-6. doi: 10.1136/jmg.2006.045880. J Med Genet. 2007. PMID: 17475917 Free PMC article.
-
The relationship between genotype and phenotype in cystic fibrosis.Curr Opin Pulm Med. 1995 Nov;1(6):450-6. doi: 10.1097/00063198-199511000-00004. Curr Opin Pulm Med. 1995. PMID: 9363081 Review.
-
The cystic fibrosis transmembrane conductance regulator gene.Am J Respir Crit Care Med. 1995 Mar;151(3 Pt 2):S47-53. doi: 10.1164/ajrccm/151.3_Pt_2.S47. Am J Respir Crit Care Med. 1995. PMID: 7533605 Review.
Cited by
-
Restoration of the cystic fibrosis transmembrane conductance regulator function by splicing modulation.EMBO Rep. 2004 Nov;5(11):1071-7. doi: 10.1038/sj.embor.7400273. EMBO Rep. 2004. PMID: 15472711 Free PMC article.
-
Alternative splicing of the ovine CFTR gene.Mamm Genome. 2003 Nov;14(11):778-87. doi: 10.1007/s00335-003-3013-1. Mamm Genome. 2003. PMID: 14722727
-
Disruption of the splicing enhancer sequence within exon 27 of the dystrophin gene by a nonsense mutation induces partial skipping of the exon and is responsible for Becker muscular dystrophy.J Clin Invest. 1997 Nov 1;100(9):2204-10. doi: 10.1172/JCI119757. J Clin Invest. 1997. PMID: 9410897 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical